Sabeti S, Ternifi R, Larson N, Olson M, Atwell T, Fatemi M
Front Oncol. 2023; 13:1121664.
PMID: 37124492
PMC: 10134399.
DOI: 10.3389/fonc.2023.1121664.
Chartampilas E, Rafailidis V, Georgopoulou V, Kalarakis G, Hatzidakis A, Prassopoulos P
Cancers (Basel). 2022; 14(16).
PMID: 36010991
PMC: 9406360.
DOI: 10.3390/cancers14163997.
Chen F, Wang F, Sun S, Zhu M, Liu Z
BMC Gastroenterol. 2020; 20(1):390.
PMID: 33213375
PMC: 7678053.
DOI: 10.1186/s12876-020-01535-1.
Bae J, Lee J, Jeon S, Jang S
Ultrasonography. 2019; 39(1):85-93.
PMID: 31759383
PMC: 6920623.
DOI: 10.14366/usg.19033.
Corvino A, Sandomenico F, Setola S, Corvino F, Tafuri D, Catalano O
J Ultrasound. 2019; 22(3):251-259.
PMID: 31087277
PMC: 6704192.
DOI: 10.1007/s40477-019-00385-2.
Assessment of image quality of contrast-enhanced power doppler imaging in hepatocellular carcinoma with the personal ultrasound imager: Comparison with the conventional machine.
Wen Y, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H
J Med Ultrason (2001). 2016; 30(1):31-8.
PMID: 27285152
DOI: 10.1007/BF02485167.
Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.
Wen Y, Kudo M, Minami Y, Chung H, Suetomi Y, Onda H
J Med Ultrason (2001). 2016; 30(3):141-51.
PMID: 27278304
DOI: 10.1007/BF02481219.
Contrast-enhanced ultrasonography using levovist: Usefulness of diagnosis of small focal nodular hyperplasia lesions.
Miura Y, Kondo K, Oikawa J, Kuroda H, Kasai K, Yamada M
J Med Ultrason (2001). 2016; 29(3):99-104.
PMID: 27277883
DOI: 10.1007/BF02481231.
Evaluation of image quality of personal ultrasound imager: Comparison with the conventional machine.
Wen Y, Kudo M, Maekawa K, Kawasaki T, Chung H, Minami Y
J Med Ultrason (2001). 2016; 29(2):41-6.
PMID: 27277739
DOI: 10.1007/BF02481438.
Characteristic power Doppler sonographic images of tumorous and non-tumorous buccal space lesions.
Ogura I, Kaneda T, Sasaki Y, Sekiya K, Tokunaga S
Dentomaxillofac Radiol. 2013; 42(7):20120460.
PMID: 23520393
PMC: 3699975.
DOI: 10.1259/dmfr.20120460.
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.
Hennedige T, Venkatesh S
Cancer Imaging. 2013; 12:530-47.
PMID: 23400006
PMC: 3666429.
DOI: 10.1102/1470-7330.2012.0044.
Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.
Loria F, Loria G, Basile S, Crea G, Randazzo D, Frosina L
Updates Surg. 2012; 64(4):247-55.
PMID: 23055349
DOI: 10.1007/s13304-012-0179-7.
Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
Mandai M, Koda M, Matono T, Nagahara T, Sugihara T, Ueki M
Br J Radiol. 2010; 84(1002):499-507.
PMID: 20959373
PMC: 3473627.
DOI: 10.1259/bjr/38682601.
Clinician performed resuscitative ultrasonography for the initial evaluation and resuscitation of trauma.
Gillman L, Ball C, Panebianco N, Al-Kadi A, Kirkpatrick A
Scand J Trauma Resusc Emerg Med. 2009; 17:34.
PMID: 19660123
PMC: 2734531.
DOI: 10.1186/1757-7241-17-34.
Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
DOnofrio M, Faccioli N, Zamboni G, Malago R, Caffarri S, Fattovich G
Radiol Med. 2008; 113(7):978-91.
PMID: 18779929
DOI: 10.1007/s11547-008-0316-z.
Current role of ultrasound for the management of hepatocellular carcinoma.
Maruyama H, Yoshikawa M, Yokosuka O
World J Gastroenterol. 2008; 14(11):1710-9.
PMID: 18350602
PMC: 2695911.
DOI: 10.3748/wjg.14.1710.
Diagnosis of hepatocellular carcinoma.
Bialecki E, Di Bisceglie A
HPB (Oxford). 2008; 7(1):26-34.
PMID: 18333158
PMC: 2023919.
DOI: 10.1080/13651820410024049.
Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.
Maruyama H, Ebara M
Int J Clin Oncol. 2006; 11(4):258-67.
PMID: 16937299
DOI: 10.1007/s10147-006-0585-2.
The distribution of microvascular response in Achilles tendonopathy assessed by colour and power Doppler.
Richards P, Win T, Jones P
Skeletal Radiol. 2005; 34(6):336-42.
PMID: 15785932
DOI: 10.1007/s00256-004-0834-2.
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation.
Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H
Cancer Sci. 2004; 95(6):547-52.
PMID: 15182438
PMC: 11158080.
DOI: 10.1111/j.1349-7006.2004.tb03247.x.